Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation

Journal of Neurogastroenterology and Motility

Volumn 21, Issue 1, 2015, Pages 111-120

  Kim, Seong Eun ^a   Choi, Suck Chei ^b   Park, Kyung Sik ^c   Park, Moo In ^d   Shin, Jeong Eun ^e   Lee, Tae Hee ^f   Jung, Kee Wook ^g   Koo, Hoon Sup ^h   Myung, Seung Jae ^g  

^a Ewha Womans University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

^c Keimyung University   (South Korea)

^d Kosin University   (South Korea)

^e Dankook University   (South Korea)

^f Soonchunhyang University   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Konyang University   (South Korea)

Author keywords

Constipation; Microbiome; Probiotics

Indexed keywords

PROBIOTIC AGENT; VSL3;

ADULT; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; BLOATING; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DRUG EFFICACY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; LACTOBACILLUS; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SHORT COURSE THERAPY; SYMPTOMATOLOGY;

EID: 84920278098     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm14048     Document Type: Article

References (36)

1. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-519.
2. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984;86:174-193.
3. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-884.
4. Husebye E, Hellström PM, Midtvedt T. Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig Dis Sci 1994;39:946-956.
5. Caenepeel P, Janssens J, Vantrappen G, Eyssen H, Coremans G. Interdigestive myoelectric complex in germ-free rats. Dig Dis Sci 1989;34:1180-1184.
6. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 1998;87:836-841.
7. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.
8. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005;37: 838-849.
9. Chassard C, Dapoigny M, Scott KP, et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 2012;35:828-838.
10. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65: 4799-4807.
11. Malinen E, Rinttilä T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373-382.
12. Ouwehand AC, Lagström H, Suomalainen T, Salminen S. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 2002;46:159-162.
13. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003;17:655-659.
14. Yang YX, He M, Hu G, et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 2008;14:6237-6243.
15. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991;32:73-79.
16. Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2010;2:19.
17. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
18. Kirgizov IV, Sukhorukov AM, Dudarev VA, Istomin AA. Hemostasis in children with dysbacteriosis in chronic constipation. Clin Appl Thromb Hemost 2001;7:335-338.
19. Nakamura T, Nishida S, Mizutani M, Iino H. Effects of yogurt supplemented with brewer's yeast cell wall on constipation and intestinal microflora in rats. J Nutr Sci Vitaminol 2001;47:367-372.
20. Riezzo G, Orlando A, D'Attoma B, et al. Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation-a double-blind, controlled, crossover study. Aliment Pharmacol Ther 2012;35:441-450.
21. Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007;20:593-621.
22. Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002;16:587-593.
23. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 2011;46: 1057-1064.
24. Borriello SP. Bacteria and gastrointestinal secretion and motility. Scand J Gastroenterol Suppl 1984;93:115-121.
25. Verdú EF, Bercik P, Collins SM. Effect of probiotics on gastrointestinal function: evidence from animal models. Therap Adv Gastroenterol 2009;2:31-35.
26. Valerio F, Russo F, de Candia S, et al. Effects of probiotic Lactobacillus paracasei-enriched artichokes on constipated patients: a pilot study. J Clin Gastroenterol 2010;44(suppl 1):S49-S53.
27. Verdú EF, Bercik P, Verma-Gandhu M, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006;55:182-190.
28. Kleessen B, Sykura B, Zunft HJ, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997;65:1397-1402.
29. Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J Gastroenterol 2010;16:69-75.
30. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000;130:396S-402S.
31. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895-904.
32. Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231-1238.
33. Agrawal A, Houghton LA, Morris J, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2009; 29:104-114.
34. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C. Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment Pharmacol Ther 2005; 22:495-512.
35. Bekkali NL, Bongers ME, Van den Berg MM, Liem O, Benninga MA. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutr J 2007;6:17.
36. Salminen S, von Wright A, Morelli L, et al. Demonstration of safety of probiotics-a review. Int J Food Microbiol 1998;44:93-106.